On what basis could you possibly say I'm a poor investor.
Had you followed my PFE suggestions, you'd have made money, as I have.
If the WYE deal fails, nothing could keep PFE from falling under $10. Its stand alone consensus EPS for 2014 is $1.45. At a P/E of eight, that's $11.60. Discounting back at 7% per annum gets you to $8.07 for 2009.
PFE won't be able to maintain even its current halved dividend without Lipitor, but at eight bucks, it might be a buy for whatever dividend it could sustain until patent expirations start to take big bites out again a few years after 2014. At 40 cent annual dividend at $8 yields 5%.